A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.
Journal
Neurology. Genetics
ISSN: 2376-7839
Titre abrégé: Neurol Genet
Pays: United States
ID NLM: 101671068
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
15
10
2021
accepted:
09
05
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
To recruit and characterize a national cohort of individuals who have a genetic variant ( In partnership with 23andMe, Inc., a personal genetics company, Over 15 months, we enrolled 277 An entirely remote national cohort of
Sections du résumé
Background and Objectives
UNASSIGNED
To recruit and characterize a national cohort of individuals who have a genetic variant (
Methods
UNASSIGNED
In partnership with 23andMe, Inc., a personal genetics company,
Results
UNASSIGNED
Over 15 months, we enrolled 277
Discussion
UNASSIGNED
An entirely remote national cohort of
Identifiants
pubmed: 35966918
doi: 10.1212/NXG.0000000000200008
pii: NNG-2022-200011
pmc: PMC9372873
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e200008Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Mov Disord. 2010 Aug 15;25(11):1652-9
pubmed: 20533449
Mov Disord. 2016 Aug;31(8):1192-202
pubmed: 27091104
Neurology. 2017 Sep 12;89(11):1152-1161
pubmed: 28814455
Eur J Neurol. 2010 Feb;17(2):194-201
pubmed: 19780808
Mov Disord. 2017 May;32(5):726-738
pubmed: 28370517
Mov Disord. 2015 Jun;30(7):981-6
pubmed: 25809001
Mov Disord. 2013 Dec;28(14):1966-71
pubmed: 24243757
Stroke. 2020 Aug;51(8):2580-2586
pubmed: 32716819
Mov Disord. 2020 Nov;35(11):1897-1902
pubmed: 32870517
Nat Rev Drug Discov. 2018 Sep;17(9):641-659
pubmed: 30093643
Nat Cancer. 2020 Jun;1(6):568-572
pubmed: 35121973
J Parkinsons Dis. 2020;10(3):855-873
pubmed: 32444562
J Huntingtons Dis. 2014;3(2):189-95
pubmed: 25062861
J Parkinsons Dis. 2020;10(4):1779-1786
pubmed: 32894251
J Parkinsons Dis. 2020;10(3):1195-1207
pubmed: 32568109
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
Mov Disord. 2020 May;35(5):833-844
pubmed: 32073681
Mov Disord. 2018 Jul;33(6):966-973
pubmed: 29603409
Ann Neurol. 2020 Nov;88(5):863-866
pubmed: 32869367
PLoS One. 2015 Jul 15;10(7):e0132368
pubmed: 26177462
Annu Rev Med. 2021 Jan 27;72:151-166
pubmed: 32735764
Neurology. 2020 Jan 7;94(1):30-38
pubmed: 31801829
Nat Rev Drug Discov. 2020 Oct;19(10):662-663
pubmed: 32913212
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
Nat Rev Neurol. 2020 Feb;16(2):97-107
pubmed: 31980808
Neurodegeneration. 1995 Mar;4(1):93-7
pubmed: 7600189
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Mov Disord. 2021 Apr;36(4):1005-1010
pubmed: 33314351
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Curr Neurol Neurosci Rep. 2018 Jun 8;18(8):44
pubmed: 29884970
Mov Disord. 2014 Jul;29(8):1035-43
pubmed: 24862344
Neurol Clin Pract. 2020 Feb;10(1):7-14
pubmed: 32190415
Nat Neurosci. 2021 Mar;24(3):297-311
pubmed: 33526943
Clin Park Relat Disord. 2021 May 24;4:100094
pubmed: 34316671
Lancet Neurol. 2008 Jul;7(7):583-90
pubmed: 18539534
BMJ. 2019 Oct 16;367:l5688
pubmed: 31619392
Mov Disord. 2007 Dec;22(16):2386-93
pubmed: 17894337
J Gerontol A Biol Sci Med Sci. 2012 Apr;67(4):433-9
pubmed: 21934125
Lancet Neurol. 2020 Jan;19(1):71-80
pubmed: 31678032
Mov Disord. 2000 Nov;15(6):1221-4
pubmed: 11104209
Mov Disord. 2015 Nov;30(13):1834-9
pubmed: 26366513
Sci Data. 2020 Feb 24;7(1):67
pubmed: 32094335
J Parkinsons Dis. 2015;5(3):505-15
pubmed: 26406130
Parkinsonism Relat Disord. 2009 May;15(4):258-62
pubmed: 18693062
Ann Clin Transl Neurol. 2014 Sep;1(9):670-8
pubmed: 25493281
Digit Health. 2015 Jun 29;1:2055207615592998
pubmed: 29942542